跳至主要内容
临床试验/ACTRN12622000823774
ACTRN12622000823774尚未招募1 期

Individualization of caffeine supplementation in adult athletes aged 18 to 30 based on the analysis of HRV

Poznan University of Medical Sciences0 个研究点目标入组 300 人开始时间: 2022年6月10日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Diagnosis
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 30 Years(—)
性别
All

入选标准

  • •Healthy athletes and healthy volunteers

排除标准

  • •lack of informed consent to participate in research,
  • •hypersensitivity to caffeine due to the polymorphism of the CYP1A2 gene
  • •diseases of the cardiovascular system,
  • •chronic disease impairing the functioning of the musculoskeletal system,
  • •diabetes,
  • •epilepsy,
  • •pregnancy,
  • •infections,
  • •inflammatory diseases,
  • •stroke history,
  • •oncological diseases,
  • •electronic life support systems (pacemakers, active prostheses, etc.)
  • •use of preparations that interact with caffeine, i.e. ephedrine, theophylline, and echinacea
  • •hypertension (over 140/90 mmHg)

研究者

发起方
Poznan University of Medical Sciences

相似试验